1
|
Xia J, Wu W, Huang X, Jiang F, Zhu S, Chen L, Fan X. Isolation, characterization, identification and quantification of 6-F oxyphenisatin dipropionate, a novel illegal additive, from a fruit-flavored jelly. Heliyon 2024; 10:e29902. [PMID: 38707292 PMCID: PMC11066336 DOI: 10.1016/j.heliyon.2024.e29902] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2023] [Revised: 04/06/2024] [Accepted: 04/17/2024] [Indexed: 05/07/2024] Open
Abstract
Objective This study is aimed to screen, identify and detect illegal additives from healthcare products which claim or imply to have weight-loss effects. Method Ultra-high performance liquid chromatography-quadruple-time-of-flight mass spectroscopy (UPLC-Q-TOF/MS) was employed to perform non-targeted screening of illegal additives from a total of 26 batches of healthcare products with weight-loss effects. A novel oxyphenisatin dipropionate analog was discovered in a fruit-flavored jelly that was not clearly labeled as containing added drugs. After being separated and purified by silica gel column chromatography, the analog was unambiguously characterized by one-dimensional (1D) and two-dimensional (2D) nuclear magnetic resonance (NMR) spectroscopies. The molecular structure of the analog was finally identified by comparing the spectra of the analog with those of suspected candidates prepared by de novo synthesis strategy. Thereafter, a sensitive and precise reversed phase ultra performance liquid chromatography coupled with photodiode array (UPLC-PDA) detection method was developed and verified for the determination of the analog in 15 batches of real samples. Results In the MS/MS spectra, the signal intensity of mass/charge ratios (m/z, 242 and 214) of the novel analog fragments was highly similar to that of mass/charge ratios (m/z, 224 and 196) of oxyphenisatin dipropionate fragments. Additionally, the 1D NMR spectrum of the analog was completely consistent with that of one of the suspected candidates prepared by the de novo synthesis strategy. Based on the above analysis, the structure of the analog was determined as 3,3-bis[4'-(propionyloxy)phenyl]-6-fluoro-2-oxoindoline, which was briefly named 6-F oxyphenisatin dipropionate. A developed quantitative method showed good linearity (R2 > 0.999) in a concentration range of 1.0-100 μg/mL. The limits of detection (LOD) and quantification (LOQ) for the analog was 3 mg/kg and 10 mg/kg, respectively. The average recoveries of the analog from spiked three different matrix samples in low (1 time of LOQ), medium (2 times of LOQ), and high (10 times of LOQ) concentrations were varied from 93.9 % to 107.8 % with a precision of 0.03-1.56 %. Results of quantitative analysis in 15 batches of healthcare products revealed that the content of 6-F oxyphenisatin dipropionate in a fruit-flavored jelly and a solid beverage was 118 mg/kg and 330 mg/kg, respectively. Conclusion In terms of its structure, 6-F oxyphenisatin dipropionate replaces hydrogen atom by the fluorine atom at position 6 on the indolinone fragment in oxyphenisatin dipropionate. To our best knowledge, 6-F oxyphenisatin dipropionate has never been detected as an illegal additive in foods. Such illegal addition of the analog to foods is more concealing, thus the supervision and testing departments should attach great importance to its application in food markets.
Collapse
Affiliation(s)
- Jintao Xia
- Hubei Provincial Institute for Food Supervision and Test, Wuhan, 430075, China
- Key Laboratory of Detection Technology of Focus Chemical Hazards in Animal-derived Food for State Market Regulation, Wuhan, 430075, China
- Hubei Provincial Engineering and Technology Research Center for Food Quality and Safety Test, Wuhan, 430075, China
| | - Wanqin Wu
- Hubei Provincial Institute for Food Supervision and Test, Wuhan, 430075, China
- Key Laboratory of Detection Technology of Focus Chemical Hazards in Animal-derived Food for State Market Regulation, Wuhan, 430075, China
- Hubei Provincial Engineering and Technology Research Center for Food Quality and Safety Test, Wuhan, 430075, China
| | - Xiuxiu Huang
- Huanggang Central Hospital, Huanggang, 438000, China
| | - Feng Jiang
- Hubei Provincial Institute for Food Supervision and Test, Wuhan, 430075, China
- Key Laboratory of Detection Technology of Focus Chemical Hazards in Animal-derived Food for State Market Regulation, Wuhan, 430075, China
- Hubei Provincial Engineering and Technology Research Center for Food Quality and Safety Test, Wuhan, 430075, China
| | - Songsong Zhu
- Hubei Provincial Institute for Food Supervision and Test, Wuhan, 430075, China
- Key Laboratory of Detection Technology of Focus Chemical Hazards in Animal-derived Food for State Market Regulation, Wuhan, 430075, China
- Hubei Provincial Engineering and Technology Research Center for Food Quality and Safety Test, Wuhan, 430075, China
| | - Li Chen
- Hubei Provincial Institute for Food Supervision and Test, Wuhan, 430075, China
- Key Laboratory of Detection Technology of Focus Chemical Hazards in Animal-derived Food for State Market Regulation, Wuhan, 430075, China
- Hubei Provincial Engineering and Technology Research Center for Food Quality and Safety Test, Wuhan, 430075, China
| | - Xiaolong Fan
- Hubei Provincial Institute for Food Supervision and Test, Wuhan, 430075, China
- Key Laboratory of Detection Technology of Focus Chemical Hazards in Animal-derived Food for State Market Regulation, Wuhan, 430075, China
- Hubei Provincial Engineering and Technology Research Center for Food Quality and Safety Test, Wuhan, 430075, China
| |
Collapse
|
2
|
Kee CL, Ge X, Low MY, Gilard V, Malet-Martino M. Analytical methods for the detection and characterization of unapproved phosphodiesterase type 5 inhibitors (PDE-5i) used in adulteration of dietary supplements- a review. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2023; 40:1495-1530. [PMID: 38011602 DOI: 10.1080/19440049.2023.2279567] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2023] [Accepted: 10/31/2023] [Indexed: 11/29/2023]
Abstract
This article is an up-to-date review of 112 unapproved phosphodiesterase type 5 inhibitors (PDE-5i) found as adulterants in sexual enhancement dietary supplements and other products from 2003 to July 2023. Seventy-five of these unapproved PDE-5i are analogues of sildenafil (67%), followed by 26 analogues of tadalafil (23%), 9 analogues of vardenafil (8%) and 2 other type of compounds (2%). The products have been formulated in various packaging, primarily in capsule, tablet, and powder forms. Common screening techniques allowing detection of such analogues include high performance or ultra-high performance liquid chromatography in tandem with ultra-violet detector (HPLC-UV or UPLC-UV) (50%) and thin-layer chromatography in tandem with ultra-violet detection (TLC-UV) (7%). Screening by mass spectrometry (MS) is relatively less common with the use of single-, triple-quadrupole or time-of-flight (TOF) mass spectrometers (9%). Meanwhile, the combined detection by UV-MS has been recorded at 10% usage. Screening by proton nuclear magnetic resonance spectroscopy (NMR) (11%) has also been applied. For compound characterization, i.e. structural elucidation, NMR spectroscopy has been preferred (100 out of 112 compounds), followed by high-resolution mass spectrometry (HRMS) (74 out of 112 compounds) and Fourier-transform infrared spectroscopy (FTIR) (44 out of 112 compounds). Over the past two decades, analytical technology has been evolving with enhanced sensitivity and resolution. Despite this, structural elucidation of the new emerging analogues in adulterated dietary supplements remains a challenge, especially when the analogues involve complex structural modification. Therefore, the above-mentioned techniques may not be adequate to characterize the analogues. Additional work involving chiroptical methods, two-dimensional (2D) NMR experiments and X-ray crystallography are likely to be required in the future.
Collapse
Affiliation(s)
- Chee-Leong Kee
- Pharmaceutical Laboratory, Applied Sciences Group, Health Sciences Authority, Singapore
| | - Xiaowei Ge
- Pharmaceutical Laboratory, Applied Sciences Group, Health Sciences Authority, Singapore
| | - Min-Yong Low
- Pharmaceutical Laboratory, Applied Sciences Group, Health Sciences Authority, Singapore
| | - Véronique Gilard
- Laboratoire IMRCP (UMR CNRS 5623), Université Paul Sabatier, Université de Toulouse, Toulouse cedex, France
| | - Myriam Malet-Martino
- Laboratoire SPCMIB (UMR CNRS 5068), Université Paul Sabatier, Université de Toulouse, Toulouse cedex, France
| |
Collapse
|
3
|
Falconer TM, Schneider B, Baessmann C, Wendt K, Filipenko A. Combining trapped ion mobility spectrometry with liquid chromatography and tandem mass spectrometry for analysis of isomeric PDE-5 inhibitor analogs. J Pharm Biomed Anal 2023; 225:115210. [PMID: 36586385 DOI: 10.1016/j.jpba.2022.115210] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2022] [Revised: 12/08/2022] [Accepted: 12/17/2022] [Indexed: 12/24/2022]
Abstract
The detection and identification of phosphodiesterase type 5 enzyme (PDE-5) inhibitors in dietary supplements poses an analytical challenge due to the large number of analogs and isomers currently available and the continued introduction of novel analogs. The use of trapped ion mobility spectrometry (TIMS) in conjunction with liquid chromatography (LC) and electrospray ionization tandem mass spectrometry (MS/MS) was explored for the analysis of two groups of isomeric PDE-5 inhibitor analogs using a 5-minute method. Of the eight compounds studied, six were resolved by a combination of LC and TIMS; the two remaining isomers were distinguished by one or more unique product ions in the MS/MS spectrum. The results revealed that separation by LC corresponded to differences in substitution on the piperazine moiety of the PDE-5 inhibitors, while separation by TIMS corresponded to the position of a nitrogen atom in the fused ring region of the molecules. Samples prepared by spiking mixtures of varying amounts of the Group 2 isomers into a representative dietary supplement matrix were analyzed and concentrations determined from the mobility-adjusted extracted ion chromatograms exhibited relative standard deviations of 6.0 % or less for 17 of 20 measurements and recoveries between 80 % and 120 % for all measurements. Quantitative measurements from a short LC gradient were possible due to the reduced chemical background associated with the TIMS separation of co-eluting matrix compounds, which enabled acquisition of rapid and qualitatively relevant broadband collision induced dissociation spectra that didn't require precursor ion isolation; the reduced chemical background permits non-targeted detection of novel analogs and eliminates the need for a separate method for quantitative measurement.
Collapse
Affiliation(s)
- Travis M Falconer
- US Food and Drug Administration, Office of Regulatory Affairs, Office of Regulatory Science, Forensic Chemistry Center, Cincinnati, OH, USA.
| | - Birgit Schneider
- Bruker Daltonics & Co. KG, Solutions Development, Applied Markets & Characterization, Bremen, Germany
| | - Carsten Baessmann
- Bruker Daltonics & Co. KG, Solutions Development, Applied Markets & Characterization, Bremen, Germany
| | - Karin Wendt
- Bruker Daltonics & Co. KG, Solutions Development, Applied Markets & Characterization, Bremen, Germany
| | | |
Collapse
|
4
|
Fukiwake T, Enomoto K, Yoshino H, Uchimoto K, Nishimura M, Akiyama H. [Pharmaceutical Ingredients Detected in Dietary Supplements Purchased by Chiba Prefecture (Fiscal Years 2014-2021)]. SHOKUHIN EISEIGAKU ZASSHI. JOURNAL OF THE FOOD HYGIENIC SOCIETY OF JAPAN 2022; 63:141-150. [PMID: 36047090 DOI: 10.3358/shokueishi.63.141] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
In the pharmaceutical ingredients contamination testing of 702 commercial dietary supplement products, during fiscal years 2014-2021, 14 pharmaceutical ingredients, barrenwort, leaf axils of senna, and small leaf of senna were detected in 28 products. Screening and confirmation of the pharmaceutical ingredients in the products were performed by ultra-high performance liquid chromatography with photodiode array detector and ultra-high performance liquid chromatography-quadrupole-kingdon trap mass spectrometry, respectively. In particular, leaf axils and small leaf of senna were identified by stereomicroscopy and scanning electron microscopy. Furthermore, we found several pharmaceutical ingredients that exceeded the daily medicated dosage; therefore, it is important to prevent the distribution of such products to prevent the occurrence of health hazard. For that reason, it is necessary to continue the sample purchasing and testing systems to monitor the distribution of products containing pharmaceutical ingredients.
Collapse
Affiliation(s)
- Tomohide Fukiwake
- Chiba Prefectural Institute of Public Health
- Graduate School of Pharmacy, Hoshi University
| | | | | | | | | | - Hiroshi Akiyama
- Graduate School of Pharmacy, Hoshi University
- National Institute of Health Sciences
| |
Collapse
|
5
|
Fukiwake T, Yamazaki M, Takahashi K, Doi T, Kawaguchi M, Enomoto K, Yoshino H, Uchimoto K, Nishimura M. [The Configuration of Tadalafil and Tadalafil Analogues Found in Dietary Supplements]. Food Hygiene and Safety Science (Shokuhin Eiseigaku Zasshi) 2021; 62:65-72. [PMID: 33883338 DOI: 10.3358/shokueishi.62.65] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
This study determined the configuration of the isomers of tadalafil, nortadalafil, and homotadalafil in dietary supplements. The products purchased over the Internet studied included a honey product and a tablet, which contained tadalafil, and a candy, which contained nortadalafil and homotadalafil. Each of the pharmaceutical ingredients isolated from the products was measured with circular dichroism (CD).As a result, the CD spectrum of each isolated pharmaceutical ingredient was found to align with the standard CD spectrum of the 6R,12aR isomer, confirmed that each isolated tadalafil or tadalafil analogue included in a 6R,12aR isomer. According to a report, among the stereoisomers of tadalafil, the 6R,12aR isomers have the most potent inhibitory activities of phosphodiesterase-type-5. From the report, the potential strength of the inhibitory activity of the 6R,12aR isomers of nortadalafil and homotadalafil was suggested. Therefore, it seemed that the 6R,12aR isomer often used in the product.
Collapse
|
6
|
Tachikawa H, Nishiyama R, Ichikawa-Kaji Y, Uemura N, Takaku Y, Kishimoto K, Ono Y, Tayama K, Suzuki T, Suzuki J, Moriyasu T. Structure elucidation of a PDE5 inhibitor detected as an illegal adulteration in a libido-boosting dietary supplement. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2020; 37:2023-2032. [PMID: 33136535 DOI: 10.1080/19440049.2020.1826582] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
A compound with potent inhibitory activity for phosphodiesterase type 5 (PDE5) was identified as an illegal adulteration in a libido-boosting dietary supplement being sold at a store in Tokyo. This compound was identified as 5,6-diethyl-2-{5-[(4-methylpiperazin-1-yl)sulphonyl]-2-propoxyphenyl}pyrimidin-4(3H)-one using liquid chromatography-diode array detector (LC-DAD), liquid chromatography-tandem mass spectrometer (LC-MS), LC-HRMS, nuclear magnetic resonance (NMR), and X-ray crystallography. The IC50 value of the inhibitory activity for PDE5A1 (one of the PDE5 isoforms) was 2.0 nM (sildenafil IC50 value was 4.5 nM). This compound was previously synthesised as a PDE5 inhibitor by Shanghai Institute of Materia Medica. The dietary supplement contained 85 mg of this compound in a capsule, which was about 26% of the capsule content (320 mg).
Collapse
Affiliation(s)
- Hajime Tachikawa
- Department of Pharmaceutical Sciences, Tokyo Metropolitan Institute of Public Health , Tokyo, Japan
| | - Rei Nishiyama
- Department of Pharmaceutical Sciences, Tokyo Metropolitan Institute of Public Health , Tokyo, Japan
| | - Yoko Ichikawa-Kaji
- Department of Pharmaceutical Sciences, Tokyo Metropolitan Institute of Public Health , Tokyo, Japan
| | - Nozomi Uemura
- Department of Pharmaceutical Sciences, Tokyo Metropolitan Institute of Public Health , Tokyo, Japan
| | - Yasuhiro Takaku
- Department of Pharmaceutical Sciences, Tokyo Metropolitan Institute of Public Health , Tokyo, Japan
| | - Kiyoko Kishimoto
- Department of Pharmaceutical Sciences, Tokyo Metropolitan Institute of Public Health , Tokyo, Japan
| | - Yasushi Ono
- Department of Pharmaceutical Sciences, Tokyo Metropolitan Institute of Public Health , Tokyo, Japan
| | - Kuniaki Tayama
- Department of Pharmaceutical Sciences, Tokyo Metropolitan Institute of Public Health , Tokyo, Japan
| | - Toshinari Suzuki
- Department of Pharmaceutical Sciences, Tokyo Metropolitan Institute of Public Health , Tokyo, Japan
| | - Jin Suzuki
- Department of Pharmaceutical Sciences, Tokyo Metropolitan Institute of Public Health , Tokyo, Japan
| | - Takako Moriyasu
- Department of Pharmaceutical Sciences, Tokyo Metropolitan Institute of Public Health , Tokyo, Japan
| |
Collapse
|